News

14/02/2019

REGISTRATION OPEN: From ADVANCE To VAC4EU conference

EU Ecosystem For Monitoring Of Post-Licensure Vaccine Benefit And Risk: From ADVANCE To Vac4EU conference will be held in Brussels, Belgium on 6th March 2019. Venue:Royal AcademyRue Ducale 11000 Brussels, Belgium The ADVANCE...
07/02/2019

The knowledge discovery cube framework: a reference framework for collaborative, information-driven pharmacovigilance

PhD Defence Dimitra Pappa The knowledge discovery cube framework: a reference framework for collaborative, information-driven pharmacovigilance PhD student Dimitra Pappa Dissertation available here.
30/01/2019

ADVANCE at Global Vaccine Data Network

The Project Coordinator of ADVANCE Prof Miriam Sturkenboom will present the project outcomes during the Global Vaccine Data Network meeting on January 28-30th.
08/01/2019

Vaccine Semantics. Automatic methods for recognizing, representing, and reasoning about vaccine-related information

PhD Defence B.F.H. Becker Vaccine Semantics. Automatic methods for recognizing, representing, and reasoning about vaccine-related information PhD student B.F.H. Becker  Promotor Prof.dr. M.C.J.M. Sturkenboom  Co-promotor dr....
21/12/2018

From ADVANCE To VAC4EU conference

EU Ecosystem For Monitoring Of Post-Licensure Vaccine Benefit And Risk: From ADVANCE To Vac4EU conference will be held in Brussels, Belgium on 6th March 2019. The ADVANCE public-private consortium was launched by the Innovative Medicines...
01/11/2018

ADVANCE develops the Blueprint

The ADVANCE project was created in response to the 2009 A(H1N1) influenza pandemic which highlighted that in Europe there were several factors limiting the collaboration of the key stakeholders to collectively assess vaccine safety and...
22/10/2018

ECDC presents ADVANCE solutions at VACCINATION: SCIENTIFIC AND SOCIAL PERSPECTIVES conference

ECDC has been invited to present on vaccination coverage in the EU at the symposium of the Dutch Royal Academy of Science on “Vaccination: scientific and social perspectives”. Piotr Kramarz represented ECDC and used this as an...
02/10/2018

ADVANCE Blueprint submitted to IMI

The WP7 deliverable D7.7 Blueprint of a framework to rapidly provide scientific evidence on post-marketing vaccination benefits and risks for informed decisions has been submitted to IMI. Click here to read more.
10/09/2018

ADVANCE was presented at the Vaccine Conference 2018

On the 17th of September Professor Miriam Sturkenboom delivered the lecture titled “The ADVANCE system for monitoring benefits and risks of vaccines in EU”. Vaccine Conference is organised by Vaccine, the premier journal for those...